VAXX
Price:
$0.005
Market Cap:
$633.90K
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin ge...[Read more]
Industry
Biotechnology
IPO Date
2021-11-11
Stock Exchange
OTC
Ticker
VAXX
According to Vaxxinity, Inc.’s latest financial reports and current stock price. The company's current ROE is -0.15%. This represents a change of -99.73% compared to the average of -55.07% of the last 4 quarters.
The mean historical ROE of Vaxxinity, Inc. over the last ten years is -30.60%. The current -0.15% ROE has changed -99.51% with respect to the historical average. Over the past ten years (40 quarters), VAXX's ROE was at its highest in in the September 2021 quarter at 19.31%. The ROE was at its lowest in in the December 2023 quarter at -84.96%.
Average
-30.60%
Median
-0.42%
Minimum
-120.96%
Maximum
45.73%
Discovering the peaks and valleys of Vaxxinity, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.02%
Maximum Annual ROE = 45.73%
Minimum Annual Increase = -333.22%
Minimum Annual ROE = -120.96%
| Year | ROE | Change |
|---|---|---|
| 2023 | -0.42% | -99.65% |
| 2022 | -120.96% | 13.42% |
| 2021 | -106.65% | -333.22% |
| 2020 | 45.73% | 56.02% |
The current ROE of Vaxxinity, Inc. (VAXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-76.01%
5-year avg
-30.60%
10-year avg
-30.60%
Vaxxinity, Inc.’s ROE is greater than PaxMedica, Inc. Common Stock (-1046.98%), greater than Strategic Partners A/S (-94.35%), less than NovAccess Global Inc. (76.60%), less than Trevena, Inc. (46.51%), greater than NanoLogix, Inc. (-172.49%), less than HEALTHeUNIVERSE, Inc. (0%), greater than SmileDirectClub, Inc. (-61.09%), greater than Evelo Biosciences, Inc. (-6232.76%), less than Q BioMed Inc. (44.12%), greater than Infinity Pharmaceuticals, Inc. (-3521.35%),
| Company | ROE | Market cap |
|---|---|---|
| -1046.98% | $12.56K | |
| -94.35% | $3.72M | |
| 76.60% | $6.19K | |
| 46.51% | $10.37K | |
| -172.49% | $11.96K | |
| 0% | $1.18K | |
| -61.09% | $13.39K | |
| -6232.76% | $3.80K | |
| 44.12% | $14.51K | |
| -3521.35% | $9.05K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxxinity, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxxinity, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vaxxinity, Inc.'s ROE?
How is the ROE calculated for Vaxxinity, Inc. (VAXX)?
What is the highest ROE for Vaxxinity, Inc. (VAXX)?
What is the 3-year average ROE for Vaxxinity, Inc. (VAXX)?
What is the 5-year average ROE for Vaxxinity, Inc. (VAXX)?
How does the current ROE for Vaxxinity, Inc. (VAXX) compare to its historical average?